229 related articles for article (PubMed ID: 24824039)
1. Mammary cancer chemoprevention by withaferin A is accompanied by in vivo suppression of self-renewal of cancer stem cells.
Kim SH; Singh SV
Cancer Prev Res (Phila); 2014 Jul; 7(7):738-47. PubMed ID: 24824039
[TBL] [Abstract][Full Text] [Related]
2. Dietary chemopreventative benzyl isothiocyanate inhibits breast cancer stem cells in vitro and in vivo.
Kim SH; Sehrawat A; Singh SV
Cancer Prev Res (Phila); 2013 Aug; 6(8):782-90. PubMed ID: 23661606
[TBL] [Abstract][Full Text] [Related]
3. The Role of Forkhead Box Q1 Transcription Factor in Anticancer Effects of Withaferin A in Breast Cancer.
Kim SH; Singh KB; Hahm ER; Singh SV
Cancer Prev Res (Phila); 2021 Apr; 14(4):421-432. PubMed ID: 33509807
[TBL] [Abstract][Full Text] [Related]
4. The role of polycomb group protein Bmi-1 and Notch4 in breast cancer stem cell inhibition by benzyl isothiocyanate.
Kim SH; Singh SV
Breast Cancer Res Treat; 2015 Feb; 149(3):681-92. PubMed ID: 25663545
[TBL] [Abstract][Full Text] [Related]
5. Role of Krüppel-like Factor 4-p21
Kim SH; Singh SV
Cancer Prev Res (Phila); 2019 Mar; 12(3):125-134. PubMed ID: 30723175
[TBL] [Abstract][Full Text] [Related]
6. Disease Subtype-Independent Biomarkers of Breast Cancer Chemoprevention by the Ayurvedic Medicine Phytochemical Withaferin A.
Samanta SK; Sehrawat A; Kim SH; Hahm ER; Shuai Y; Roy R; Pore SK; Singh KB; Christner SM; Beumer JH; Davidson NE; Singh SV
J Natl Cancer Inst; 2017 Jun; 109(6):. PubMed ID: 28040797
[TBL] [Abstract][Full Text] [Related]
7. Forkhead Box Q1 Is a Novel Target of Breast Cancer Stem Cell Inhibition by Diallyl Trisulfide.
Kim SH; Kaschula CH; Priedigkeit N; Lee AV; Singh SV
J Biol Chem; 2016 Jun; 291(26):13495-508. PubMed ID: 27129776
[TBL] [Abstract][Full Text] [Related]
8. Characterization of mammary cancer stem cells in the MMTV-PyMT mouse model.
Ma J; Lanza DG; Guest I; Uk-Lim C; Glinskii A; Glinsky G; Sell S
Tumour Biol; 2012 Dec; 33(6):1983-96. PubMed ID: 22878936
[TBL] [Abstract][Full Text] [Related]
9. Cell signaling by urokinase-type plasminogen activator receptor induces stem cell-like properties in breast cancer cells.
Jo M; Eastman BM; Webb DL; Stoletov K; Klemke R; Gonias SL
Cancer Res; 2010 Nov; 70(21):8948-58. PubMed ID: 20940399
[TBL] [Abstract][Full Text] [Related]
10. Withaferin A inhibits experimental epithelial-mesenchymal transition in MCF-10A cells and suppresses vimentin protein level in vivo in breast tumors.
Lee J; Hahm ER; Marcus AI; Singh SV
Mol Carcinog; 2015 Jun; 54(6):417-29. PubMed ID: 24293234
[TBL] [Abstract][Full Text] [Related]
11. Hedgehog signaling and Bmi-1 regulate self-renewal of normal and malignant human mammary stem cells.
Liu S; Dontu G; Mantle ID; Patel S; Ahn NS; Jackson KW; Suri P; Wicha MS
Cancer Res; 2006 Jun; 66(12):6063-71. PubMed ID: 16778178
[TBL] [Abstract][Full Text] [Related]
12. Withaferin A causes activation of Notch2 and Notch4 in human breast cancer cells.
Lee J; Sehrawat A; Singh SV
Breast Cancer Res Treat; 2012 Nov; 136(1):45-56. PubMed ID: 22965833
[TBL] [Abstract][Full Text] [Related]
13. Withaferin A causes FOXO3a- and Bim-dependent apoptosis and inhibits growth of human breast cancer cells in vivo.
Stan SD; Hahm ER; Warin R; Singh SV
Cancer Res; 2008 Sep; 68(18):7661-9. PubMed ID: 18794155
[TBL] [Abstract][Full Text] [Related]
14. Nicastrin regulates breast cancer stem cell properties and tumor growth in vitro and in vivo.
Lombardo Y; Filipović A; Molyneux G; Periyasamy M; Giamas G; Hu Y; Trivedi PS; Wang J; Yagüe E; Michel L; Coombes RC
Proc Natl Acad Sci U S A; 2012 Oct; 109(41):16558-63. PubMed ID: 23012411
[TBL] [Abstract][Full Text] [Related]
15. Anti-estrogen Resistance in Human Breast Tumors Is Driven by JAG1-NOTCH4-Dependent Cancer Stem Cell Activity.
Simões BM; O'Brien CS; Eyre R; Silva A; Yu L; Sarmiento-Castro A; Alférez DG; Spence K; Santiago-Gómez A; Chemi F; Acar A; Gandhi A; Howell A; Brennan K; Rydén L; Catalano S; Andó S; Gee J; Ucar A; Sims AH; Marangoni E; Farnie G; Landberg G; Howell SJ; Clarke RB
Cell Rep; 2015 Sep; 12(12):1968-77. PubMed ID: 26387946
[TBL] [Abstract][Full Text] [Related]
16. Downregulation of CXCR7 inhibits proliferative capacity and stem cell-like properties in breast cancer stem cells.
Tang X; Li X; Li Z; Liu Y; Yao L; Song S; Yang H; Li C
Tumour Biol; 2016 Oct; 37(10):13425-13433. PubMed ID: 27460092
[TBL] [Abstract][Full Text] [Related]
17. Peptidyl-prolyl cis/trans isomerase Pin1 regulates withaferin A-mediated cell cycle arrest in human breast cancer cells.
Samanta SK; Lee J; Hahm ER; Singh SV
Mol Carcinog; 2018 Jul; 57(7):936-946. PubMed ID: 29603395
[TBL] [Abstract][Full Text] [Related]
18. Growth arrest by the antitumor steroidal lactone withaferin A in human breast cancer cells is associated with down-regulation and covalent binding at cysteine 303 of β-tubulin.
Antony ML; Lee J; Hahm ER; Kim SH; Marcus AI; Kumari V; Ji X; Yang Z; Vowell CL; Wipf P; Uechi GT; Yates NA; Romero G; Sarkar SN; Singh SV
J Biol Chem; 2014 Jan; 289(3):1852-65. PubMed ID: 24297176
[TBL] [Abstract][Full Text] [Related]
19. Vitamin D compounds reduce mammosphere formation and decrease expression of putative stem cell markers in breast cancer.
Wahler J; So JY; Cheng LC; Maehr H; Uskokovic M; Suh N
J Steroid Biochem Mol Biol; 2015 Apr; 148():148-55. PubMed ID: 25445919
[TBL] [Abstract][Full Text] [Related]
20. Oestrogen increases the activity of oestrogen receptor negative breast cancer stem cells through paracrine EGFR and Notch signalling.
Harrison H; Simões BM; Rogerson L; Howell SJ; Landberg G; Clarke RB
Breast Cancer Res; 2013 Mar; 15(2):R21. PubMed ID: 23497505
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
